ACC.17 Expo Showcases the Latest Innovations in CV Products and Services The ACC.17 Expo continues to be the largest global gathering for cardiovascular innovation, with 290 companies and organizations showcasing the latest advances in cardiology. Attendees will have a total of 19 hours to explore the exhibits on the Expo floor, where industry representatives will be on-hand to provide information on the newest innovative pharmaceuticals, imaging, devices, technologies and services needed to provide high-quality patient care. The ACC.17 Expo will be located on the Lower Level of the Walter E. Washington Convention Center, and will be open from 9:30 a.m. to 4:45 p.m. Friday, March 17 and Saturday March 18, and from 9:30 a.m. to 2:00 p.m. on Sunday, March 19. ACC.17 Expo highlights include the following Specialty Areas, Learning Destinations and dining areas: Specialty Areas ACC Central Stop by ACC Central for comprehensive information on ACC’s new and ongoing quality campaigns and initiatives, NCDR registries, accreditation services and educational selfassessment tools. Attendees will also find information on live events, membership opportunities, and tips for ensuring practice viability and protecting patient access. International Chapters An area has been set aside for representatives from 26 of the ACC’s International Chapters. Here, international members can meet and discuss issues relevant to the practice of cardiology in their home countries. Health IT Pavilion The ACC is highly committed to assisting its members in adopting and implementing health information technology (IT) to promote quality in cardiovascular care. At the Health IT Pavilion, IT companies and consultants will showcase their products, services and technologies and their benefits to health care providers. Interventional Pavilion A visit to the Interventional Pavilion will help interventional and general cardiologists keep up with the latest technologies, devices and services coming into the interventional cardiology marketplace. Patient Engagement Pavilion The Patient Engagement Pavilion highlights ACC’s commitment to quality patient-centered care. Here, presenters will showcase their programs, tools, and resources designed to empower patients, cardiovascular clinicians, and caregivers to work together to improve cardiovascular outcomes, reduce the cost of care and improve patient satisfaction. See related article on page 49. Learning Destinations Industry-Expert Theaters Stop by the Industry-Expert Theaters during scheduled daily breaks for presentations featuring information on the latest in cardiovascular practices, services and technologies. Attendees can enjoy refreshments or lunch while learning about topics like reversal agents in anticoagulation care, clinical review of a current therapy for additional LDL-C lowering, wearable cardioverter defibrillators, the role of atrial natriuretic peptides in heart failure, and new clinical trial data on a type 2 diabetes treatment. Innovation Stage The Innovation Stage is a unique venue where attendees can enjoy 30-minute presentations in a relaxed setting and intimate format that is more like a living room than a classroom. Presentations will focus on topics including the goal-oriented approach in pulmonary artery hypertension, neurogenic orthostatic hypotension, and more. Interactive Learning Labs Interactive Learning Labs will engage attendees in participatory hands-on training and interactive presentations in a classroom-like setting. Attendees will learn about new information and technologies that provide valuable tools for use in daily practice. The scheduled interactive learning sessions include topics such as “Advancing the Treatment of Heart Failure,” “Advanced Heart Failure and VAD Therapy,” “Identifying the nOH Patient in the Cardiology Clinic,” “nOH treatment,” “Orthostatics,” and more. Dining ACC.17 Expo will include a number of accessible, healthy choices for attendees to stay fueled while participating in the important meetings and sessions during the conference. The Bistro ACC will serve an all-inclusive buffet lunch with assorted menu options. Quick, to-go options will be available at other dining venues. Lundbeck to Present Unique Learning Experiences During the ACC.17 Expo Lundbeck, a global pharmaceutical company specializing in psychiatry and neurology, will offer a 30-minute Innovation Stage presentation titled Doctor, I’m Dizzy: Clinical Perspectives of Neurogenic Orthostatic Hypotension on March 18 from 1:30 – 2:00 p.m. Lundbeck will also present three Interactive Learning Lab sessions on neurogenic orthostatic hypotension (nOH), including Identifying the nOH Patient in the Cardiology Clinic on March 18 from 9:45 – 10:30 a.m.; Orthostatics: What, Where, How on March 17 from 11:30 – 12:15 p.m. and March 19 from 9:45 – 10:30 a.m.; and nOH Treatment: What it Means to Your Patient on March 17 from 12:45 – 1:30 p.m. and March 18 from 3:45 – 4:30 p.m. ACC spoke with Lundbeck U.S. about the content and format of these sessions. Would you provide an overview of the Innovation Stage presentation and Interactive Learning Lab sessions Lundbeck will present? We’re very excited about what we will be doing at ACC with these sessions. Our Innovation Stage presentation will provide a clinical overview of nOH and will explore distinction of nOH from other forms of orthostatic hypotension, underlying pathophysiology, common symptoms and patient impact, and diagnosis and management. A patient case study on diagnosis and treatment will provide audience members with relevant information they can use in their practice. Recommendations for measuring orthostatic blood pressure, a step-wise approach to treatment, and non-pharmacologic management options that patients can implement into their daily lives will be highlighted. For the Interactive Learning Labs, we have created nine 45-minute sessions, each of which will be moderated by a physician experienced in the care of patients with nOH. We are focusing each of these sessions on one particular area by building upon a patient case study that is relevant to the cardiovascular clinician. We structured the case study to specifically address screening, diagnosis, and treatment of nOH. The purpose of the sessions on screening is to discuss appropriate questions to ask patients and screening techniques specifically associated with timing of blood pressure measurements. We want to show clinicians how to make the screening process more efficient and streamlined by focusing on patients who are most at risk. The second session topic will provide clinicians with a stepwise approach to the diagnosis of nOH starting with orthostatic blood pressure measurement and heart rate, followed by autonomic testing in select cases. The last session is focused on the treatment of nOH, including nonpharmacologic measures such as adjusting salt intake, blood volume repletion, and physical conditioning, as well as pharmacologic treatments. The overall goal of the Interactive Learning Labs is to provide an environment where Lundbeck can directly interact with clinicians. We can learn from them based on their experience and share information and techniques that have recently emerged in the treatment of nOH. What drives topic selection for the presentations? NOH is an underdiagnosed disorder that can greatly impact patients. The need for better understanding of what nOH is, who it affects, and how to properly diagnose and manage symptoms is what drives the selection of this topic. What is unique about the Innovation Stage and Interactive Learning Lab settings? Both settings provide an interactive environment to examine clinical issues. A venue such as the Innovation Stage is particularly useful for topics like nOH that might be misunderstood and can benefit from an open discussion. The Interactive Learning Labs provide a unique opportunity to have a roundtable discussion with nOH experts and clinicians. We can walk clinicians through the patient case study in an interactive discussion that is not just a didactic presentation. We can create a more dynamic and meaningful way of communicating using a patient case that the clinicians can identify with. How will the education be provided? In other words, what types of learning activities will be used? The Innovation Stage presentation will consist of a single speaker presenting with PowerPoint slides. Questions and feedback from the audience will be encouraged. For the Interactive Learning Labs, we’re bringing in a physician experienced in the care of patients with nOH who can establish a connection with these clinicians – someone who has experience with screening, diagnosing and treating nOH in a cardiovascular setting. We will ask questions via iPads and gauge attendees’ experience with an audience response system. The verbal and nonverbal activities will be hands-on and interactive. What can attendees expect to gain from participating in Lundbeck’s Innovation Stage and Interactive Learning Lab sessions? Attendees will gain a better appreciation of nOH and how its cause and impact of symptoms is best addressed by proper diagnosis and management. Attendees will also learn about an additional option to consider when diagnosing patients with these symptoms. Our goal is for clinicians to walk away feeling more confident in their ability to recognize the symptoms associated with nOH. They will gain additional knowledge, tools and resources that will help them screen, diagnose and manage these patients. * Innovation Stage and Interactive Learning Lab presentations are not part of ACC.17, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.
Published by American College of Cardiology. View All Articles.
This page can be found at https://bluetoad.com/article/Partners+In+Innovation/2731587/389870/article.html.